H5N1 influenza pandemic: contingency plans.
Identifieur interne : 001E45 ( PubMed/Curation ); précédent : 001E44; suivant : 001E46H5N1 influenza pandemic: contingency plans.
Auteurs : Kenneth W T. Tsang [République populaire de Chine] ; Philip Eng ; C K Liam ; Young-Soo Shim ; Wah K. LamSource :
- Lancet (London, England) [ 1474-547X ]
Descripteurs français
- KwdFr :
- Antiviraux (usage thérapeutique), Flambées de maladies (), Grippe humaine (), Grippe humaine (traitement médicamenteux), Grippe humaine (transmission), Grippe humaine (épidémiologie), Humains, Sialidase (antagonistes et inhibiteurs), Sous-type H5N1 du virus de la grippe A, Vaccins antigrippaux, Virus de la grippe A.
- MESH :
- antagonistes et inhibiteurs : Sialidase.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Grippe humaine.
- épidémiologie : Grippe humaine.
- Flambées de maladies, Grippe humaine, Humains, Sous-type H5N1 du virus de la grippe A, Vaccins antigrippaux, Virus de la grippe A.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Disease Outbreaks (prevention & control), Humans, Influenza A Virus, H5N1 Subtype, Influenza A virus, Influenza Vaccines, Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (transmission), Neuraminidase (antagonists & inhibitors).
- MESH :
- chemical , antagonists & inhibitors : Neuraminidase.
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- prevention & control : Disease Outbreaks, Influenza, Human.
- transmission : Influenza, Human.
- Humans, Influenza A Virus, H5N1 Subtype, Influenza A virus, Influenza Vaccines.
DOI: 10.1016/S0140-6736(05)67080-8
PubMed: 16099278
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E45
Links to Exploration step
pubmed:16099278Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">H5N1 influenza pandemic: contingency plans.</title>
<author><name sortKey="Tsang, Kenneth W T" sort="Tsang, Kenneth W T" uniqKey="Tsang K" first="Kenneth W T" last="Tsang">Kenneth W T. Tsang</name>
<affiliation wicri:level="1"><nlm:affiliation>University Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR, China. kwttsang@hku.hk</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>University Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Eng, Philip" sort="Eng, Philip" uniqKey="Eng P" first="Philip" last="Eng">Philip Eng</name>
</author>
<author><name sortKey="Liam, C K" sort="Liam, C K" uniqKey="Liam C" first="C K" last="Liam">C K Liam</name>
</author>
<author><name sortKey="Shim, Young Soo" sort="Shim, Young Soo" uniqKey="Shim Y" first="Young-Soo" last="Shim">Young-Soo Shim</name>
</author>
<author><name sortKey="Lam, Wah K" sort="Lam, Wah K" uniqKey="Lam W" first="Wah K" last="Lam">Wah K. Lam</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2005 Aug 13-19</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:16099278</idno>
<idno type="pmid">16099278</idno>
<idno type="doi">10.1016/S0140-6736(05)67080-8</idno>
<idno type="wicri:Area/PubMed/Corpus">001E45</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E45</idno>
<idno type="wicri:Area/PubMed/Curation">001E45</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E45</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">H5N1 influenza pandemic: contingency plans.</title>
<author><name sortKey="Tsang, Kenneth W T" sort="Tsang, Kenneth W T" uniqKey="Tsang K" first="Kenneth W T" last="Tsang">Kenneth W T. Tsang</name>
<affiliation wicri:level="1"><nlm:affiliation>University Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR, China. kwttsang@hku.hk</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>University Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Eng, Philip" sort="Eng, Philip" uniqKey="Eng P" first="Philip" last="Eng">Philip Eng</name>
</author>
<author><name sortKey="Liam, C K" sort="Liam, C K" uniqKey="Liam C" first="C K" last="Liam">C K Liam</name>
</author>
<author><name sortKey="Shim, Young Soo" sort="Shim, Young Soo" uniqKey="Shim Y" first="Young-Soo" last="Shim">Young-Soo Shim</name>
</author>
<author><name sortKey="Lam, Wah K" sort="Lam, Wah K" uniqKey="Lam W" first="Wah K" last="Lam">Wah K. Lam</name>
</author>
</analytic>
<series><title level="j">Lancet (London, England)</title>
<idno type="eISSN">1474-547X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Humans</term>
<term>Influenza A Virus, H5N1 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza Vaccines</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (transmission)</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term>
<term>Flambées de maladies ()</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (transmission)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
<term>Sous-type H5N1 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Influenza A Virus, H5N1 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Sous-type H5N1 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
<term>Virus de la grippe A</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16099278</PMID>
<DateCompleted><Year>2005</Year>
<Month>10</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>366</Volume>
<Issue>9485</Issue>
<PubDate><MedlineDate>2005 Aug 13-19</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Lancet (London, England)</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>H5N1 influenza pandemic: contingency plans.</ArticleTitle>
<Pagination><MedlinePgn>533-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsang</LastName>
<ForeName>Kenneth W T</ForeName>
<Initials>KW</Initials>
<AffiliationInfo><Affiliation>University Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR, China. kwttsang@hku.hk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Eng</LastName>
<ForeName>Philip</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liam</LastName>
<ForeName>C K</ForeName>
<Initials>CK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Shim</LastName>
<ForeName>Young-soo</ForeName>
<Initials>YS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lam</LastName>
<ForeName>Wah K</ForeName>
<Initials>WK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053124" MajorTopicYN="Y">Influenza A Virus, H5N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="Y">Influenza A virus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16099278</ArticleId>
<ArticleId IdType="pii">S0140-6736(05)67080-8</ArticleId>
<ArticleId IdType="doi">10.1016/S0140-6736(05)67080-8</ArticleId>
<ArticleId IdType="pmc">PMC7134619</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Science. 2003 Nov 28;302(5650):1519-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645836</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Treat Respir Med. 2005;4(2):107-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15813662</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1998 Dec 12;352(9144):1877-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9863784</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Int. 2003 Jun;45(3):366-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12828601</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Infect Dis Rep. 2005 May;7(3):193-199</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15847721</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nurs Ethics. 2004;11(3):277-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15176641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacokinet. 1999;36 Suppl 1:21-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10429837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2000 Feb 23;283(8):1016-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10697061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Aug 28-Sep 3;364(9436):759-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15337401</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Commun Dis Public Health. 2003 Jun;6(2):123-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12889291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2005 Jan 27;352(4):333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15668219</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Respir Med. 1998 Jan;92(1):105-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9519233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2004 Mar 18;350(12):1179-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14985470</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001E45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:16099278 |texte= H5N1 influenza pandemic: contingency plans. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16099278" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
![]() | This area was generated with Dilib version V0.6.34. | ![]() |